Search
The transition of Value Research Online has been postponed to take care of some user concerns.
You are welcome to try out the new site at https://beta.valueresearchonline.com

Concord Drugs

Sector: Healthcare | Industry: Drugs & Pharma
R 15.35 -0.80  | -4.95% -33.26% 27.81 12.07
BSE Price: Dec 10, 2019 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
BSE Dec 10, 2019 15.35 -0.80 -4.95% 15.35 16.15 45 15.35 - 15.35
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE FREE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
6M Average Volume: 380 P/B: 0.54 NSE Code:
52-Week Range: R 13.50 - 24.35 Dividend Yield: 0.00% BSE Code: 538965
TTM EPS: R 0.55 Book Value: R 28.57 Face Value: R 10
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 37
Price Graph
  • Procter & Gamble Health (BSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Value Research Stock Advisor now has 37 stock recommendations and new ones are added every month.
Thousands of our members are using the current market conditions to buy great stocks at low prices.

Membership of this premium service is available at a 40% to 60% discount. Learn more and become a member
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Concord Drugs -32.08 -14.72 -29.26 -32.97 -32.96 - -
S&P BSE Small Cap -10.62 -2.45 3.42 -5.06 2.18 3.05 5.05
S&P BSE Healthcare -5.05 1.00 1.56 -1.67 -5.25 -2.33 10.29
Company's return has been calculated on basis of BSE's price.
As on Dec 10, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue -7.18 -1.74 7.20
Net Profit 25.58 -38.49 3.74
EPS 25.59 -40.14 2.05
Book Value 19.84 12.30 11.07
Average
Operating Margin 7.79 9.04 12.46
Net Margin 0.85 0.58 1.38
Return on Networth 1.92 1.51 4.45
Return on Investment 6.17 7.50 9.95
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue 5.88 22.65 -1.90
Operating Profit -7.61 -8.82 23.49
Net Profit -56.72 61.11 -71.71
EPS -56.72 44.76 -74.57
TTM
Revenue 5.38 -1.16 5.99
Operating Profit -2.36 3.38 -3.79
Net Profit 5.34 153.85 6.90
EPS 4.04 151.43 2.11
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Concord Drugs 12.07 50.98 0.43 0.85 1.92 0.54 27.81
Astrazeneca Pharma India 6,683.13 818.54 74.85 8.97 20.03 20.28 89.29
Procter & Gamble Health 6,936.55 894.23 835.89 14.21 73.79 8.90 51.75
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
May 14, 2019 S Koni Reddy  Buy Conversion of Security 178,000 23.00 40.94
May 14, 2019 S Koni Reddy  Sell Conversion of Security 178,000 23.00 40.94
May 14, 2019 S Manoj Kumar Reddy  Buy Conversion of Security 214,000 23.00 49.22
May 14, 2019 S Manoj Kumar Reddy  Sell Conversion of Security 214,000 23.00 49.22
May 14, 2019 S Nagi Reddy  Buy Conversion of Security 290,000 23.00 66.70
News & Announcements
Contact Information

Company: Concord Drugs Ltd.

Address: Survey No.249, Brahmanapally Village, Hayatnagar Mandal, R R Dist, Hyderabad, Telangana - 501511 | Phone: 91-040 24036379/24037763

Email: [email protected]

Website: www.concorddrugs.in

Registrar & Transfer Agent: Aarthi Consultants Pvt Ltd

Address: 1-2-285 , Domalaguda,,Hyderabad, 1-2-285, Domalaguda | Phone: 040-7642217/7634445 | Fax: 040-7632184

Essential checks
Altman Z-Score
1.28
Piotroski F-Score
7
Modified C-Score
5
3-Years Price to Earnings
27.81
3-Years Price to Book
0.54
Earnings Yield
EBIT / Enterprise value
10.36%
PEG
Price / Earnings to growth ratio
-0.60
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R2,671.15 -3.38%
Eris Lifesciences R475.80 -2.68%
FDC R206.95 -0.31%
Granules India R124.90 +2.08%
JB Chemicals & Pharma R422.35 +5.14%
Laurus Labs R334.60 -0.22%
Procter & Gamble Health R4,181.40 -1.94%
Strides Pharma Science R371.25 -0.50%
Sun Pharma Adv. Research R170.05 +4.65%
Suven Life Sciences R265.25 -1.92%
As on Dec 10, 15:59